[Translation] A single-center, open-label, randomized, single-dose, two-period, two-sequence, crossover bioequivalence study to evaluate the bioequivalence of the test preparation, tramadol acetaminophen tablets, and the reference preparation, tramadol acetaminophen tablets, in healthy adult subjects under fasting/fed conditions
主要研究目的:考察单次单剂量口服(空腹/餐后)受试制剂氨酚曲马多片(规格:盐酸曲马多37.5mg/对乙酰氨基酚325mg(1片),多多药业有限公司生产)与参比制剂氨酚曲马多片(ULTRACET®,规格:盐酸曲马多37.5mg/对乙 酰氨基酚325mg(1片),JANSSEN PHARMACEUTICALSINC生产),在中国健康人体的相对生物利用度,分析两种制剂的药代动力学参数,评价两制剂的生物等效性,为该药的申报及临床用药提供参考依据。次要研究目的:评价空腹、餐后单次口服受试制剂和参比制剂在中国成年健康受试者中的安全性。
[Translation] The main purpose of the study is to investigate the relative bioavailability of a single oral dose (fasting/postprandial) of the test preparation Tramadol Amide Tablets (Specifications: Tramadol Hydrochloride 37.5mg/Acetaminophen 325mg (1 tablet), produced by Duoduo Pharmaceutical Co., Ltd.) and the reference preparation Tramadol Amide Tablets (ULTRACET®, Specifications: Tramadol Hydrochloride 37.5mg/Acetaminophen 325mg (1 tablet), produced by JANSSEN PHARMACEUTICALSINC) in healthy Chinese subjects, analyze the pharmacokinetic parameters of the two preparations, evaluate the bioequivalence of the two preparations, and provide a reference for the application and clinical use of the drug. The secondary purpose of the study is to evaluate the safety of the test preparation and the reference preparation in Chinese healthy adult subjects after a single oral dose (fasting/postprandial).